Cannabis
Early Warning News Release
2852138 Ontario Inc. Acquisition of Securities of FinCanna Capital Corp.
Toronto, Ontario–(Newsfile Corp. – December 30, 2022) – Bob Simpson, indirectly through 2852138 Ontario Inc. (“285 Ont“) announces the acquisition of 484,006 common shares (“Shares“) and 877,500 convertible debentures (“Debentures“) of FinCanna Capital Corp. (“FinCanna” or the “Company“) at an aggregate price of $23. Each Debenture is conditionally convertible into one (1) Share of the Company at a conversion price of $0.005 per Share. Before the acquisition, 285 Ont owned, nil Shares and nil Debentures of the Company.
After the acquisition, 285 Ont owns 484,006 Shares representing approximately 0.716% of FinCanna’s outstanding Shares, representing an increase of approximately 0.716% of the Shares held by 285 Ont. Upon conditional conversion of the principal amount of the acquired 877,500 Debentures, at a conditional conversion price of $0.005 per Share, 285 Ont would own an additional 175,500,000 Shares, representing approximately 72.383% of FinCanna’s outstanding common shares on a conditionally partially converted basis, representing an increase of approximately 72.383% on a conditionally partially converted basis of the Shares held by 285 Ont.
The Shares and Debentures were acquired by 285 Ont for investment and tax planning purposes. 285 Ont may in the future dispose of some or all of the securities 285 Ont holds, depending on market conditions, tax considerations, reformulation of plans or other factors.
For more information or to obtain a copy of the early warning reports filed under National Instrument 62-103, please contact:
2852138 Ontario Inc.
Attention: Bob Simpson
Phone: 1-905-502-0100
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/149913
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III